UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Treatment Options for Urogenital Dysfunction in Parkinson's Disease

Batla, A; Tayim, N; Pakzad, M; Panicker, JN; (2016) Treatment Options for Urogenital Dysfunction in Parkinson's Disease. Current Treatment Options in Neurology , 18 (10) , Article 45. 10.1007/s11940-016-0427-0. Green open access

[thumbnail of panicker_art%3A10.1007%2Fs11940-016-0427-0.pdf]
Preview
Text
panicker_art%3A10.1007%2Fs11940-016-0427-0.pdf

Download (377kB) | Preview
[thumbnail of panicker_Table 1.pdf]
Preview
Text
panicker_Table 1.pdf

Download (173kB) | Preview
[thumbnail of panicker_Table 2.pdf]
Preview
Text
panicker_Table 2.pdf

Download (171kB) | Preview

Abstract

OPINION STATEMENT: Urogenital dysfunction is commonly reported in Parkinson's disease (PD), and history taking and a bladder diary form the cornerstone of evaluation. The assessment of lower urinary tract (LUT) symptoms include urinalysis, ultrasonography, and urodynamic studies and help to evaluate concomitant urological pathologies such as benign prostate enlargement. Antimuscarinic medications are the first line treatment for overactive bladder (OAB) symptoms and solifenacin has been specifically studied in PD. Antimuscarininc drugs may exacerbate PD-related constipation and xerostomia, and caution is advised when using these medications in individuals where cognitive impairment is suspected. Desmopressin is effective for the management of nocturnal polyuria which has been reported to be common in PD. Intradetrusor injections of botulinum toxin have been shown to be effective for detrusor overactivity, however, are associated with the risk of urinary retention. Neuromodulation is a promising, minimally invasive treatment for PD-related OAB symptoms. Erectile dysfunction is commonly reported and first line treatments include phosphodiesterase-5 inhibitors. A patient-tailored approach is required for the optimal management of urogenital dysfunction in PD.

Type: Article
Title: Treatment Options for Urogenital Dysfunction in Parkinson's Disease
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s11940-016-0427-0
Publisher version: http://doi.org/10.1007/s11940-016-0427-0
Language: English
Additional information: © The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Bladder diary Parkinson’s disease, Detrusor overactivity, Erectile dysfunction, Incontinence, Lower urinary tract, Urodynamics
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: https://discovery.ucl.ac.uk/id/eprint/1508573
Downloads since deposit
153Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item